BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

908 related articles for article (PubMed ID: 9009102)

  • 1. Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion.
    Cuvier C; Jang A; Hill RP
    Clin Exp Metastasis; 1997 Jan; 15(1):19-25. PubMed ID: 9009102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effects of two oligosaccharides on murine melanoma experimental metastasis].
    Zhou R; Wang Y
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):205-7. PubMed ID: 9596961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.
    Palomares T; Alonso-Varona A; Alvarez A; Castro B; Calle Y; Bilbao P
    Clin Exp Metastasis; 1997 May; 15(3):329-37. PubMed ID: 9174132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the larynx--a distant metastasis from a rectal primary.
    Hilger AW; Prichard AJ; Jones T
    J Laryngol Otol; 1998 Feb; 112(2):199-201. PubMed ID: 9578888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity.
    Celluzzi CM; Falo LD
    J Invest Dermatol; 1997 May; 108(5):716-20. PubMed ID: 9129221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antitumor effect of Tiazofurin (TR) consists of anti-proliferative and anti-invasive elements.
    Tóvári J; Bocsi J; Ladányi A; Lapis K; Timár J
    Anticancer Res; 1996; 16(6A):3307-12. PubMed ID: 9042305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indicine-N-oxide: the antitumor principle of Heliotropium indicum.
    Kugelman M; Liu WC; Axelrod M; McBride TJ; Rao KV
    Lloydia; 1976; 39(2-3):125-8. PubMed ID: 948236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Langerhans cell histiocytosis of the genitalia in the elderly: a report of three cases.
    Meehan SA; Smoller BR
    J Cutan Pathol; 1998 Aug; 25(7):370-4. PubMed ID: 9765022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary experience with high-dose cisplatin, reduced glutathione and natural interferon-alpha in dacarbazine-resistant malignant melanoma.
    Bajetta E; Rimassa L; Carnaghi C; Del Vecchio M; Celio L; Cassata A
    Tumori; 1998; 84(1):48-51. PubMed ID: 9619714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ras farnesylation inhibitor BZA-5B increases the resistance to cisplatin in a human melanoma cell line.
    Fokstuen T; Rabo YB; Zhou JN; Karlson J; Platz A; Shoshan MC; Hansson J; Linder S
    Anticancer Res; 1997; 17(4A):2347-52. PubMed ID: 9252645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng.
    Lee YS; Chung IS; Lee IR; Kim KH; Hong WS; Yun YS
    Anticancer Res; 1997; 17(1A):323-31. PubMed ID: 9066672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavone acetic acid enhances accumulation of IL-2 activated NK cells within established metastases.
    Kitson RP; Ohashi M; Brunson KW; Goldfarb RH
    In Vivo; 1998; 12(6):593-7. PubMed ID: 9891222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
    Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
    J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
    Nishimura MI; Custer MC; Schwarz SL; Parker LL; Mixon A; Clay TM; Yannelli JR; Rosenberg SA
    J Immunother; 1998 Sep; 21(5):352-62. PubMed ID: 9789197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant neoplastic disease of the parotid lymph nodes.
    Schroeder WA; Stahr WD
    Laryngoscope; 1998 Oct; 108(10):1514-9. PubMed ID: 9778292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of hematologic systemic diseases and rare tumor entities with manifestations in the oromaxillofacial area].
    Petrasch S
    Mund Kiefer Gesichtschir; 1998 Jul; 2(4):172-80. PubMed ID: 9738365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Triggered trap": nevoid malignant melanoma.
    McNutt NS
    Semin Diagn Pathol; 1998 Aug; 15(3):203-9. PubMed ID: 9711670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
    Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
    Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells.
    Rusciano D; Lin S; Lorenzoni P; Casella N; Burger MM
    Tumour Biol; 1998; 19(5):335-45. PubMed ID: 9701724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocytic naevus or malignant melanoma? A large-scale epidemiological study of diagnostic accuracy.
    Lindelöf B; Hedblad MA; Sigurgeirsson B
    Acta Derm Venereol; 1998 Jul; 78(4):284-8. PubMed ID: 9689297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.